The metabolism of synthetic peptide analogues of high density lipoprotein (HDL) apoproteins has been studied in the rat. These compounds are 15-amino acid lipid associating peptides (LAPs) bearing acyl chains of various lengths (0-16 carbon units). After injection of each 125I-LAP, the serum decay curves suggested a two-compartment process with a clearance rate decreasing when the acyl chain lengths increased. The similarity between the apparent half-life of C16-LAP and that of apoprotein A-I as well as the chromatographic analysis of rat serum were consistent with a partitioning of the LAPs between HDL and the aqueous phase. This was strongly dependent upon the acyl chain length of the LAPs. The distribution volumes of the 125I-LAPs in organs were measured 10 min after injection. The results were analyzed using a model explicitly predicting the organ distribution volumes of HDL and the equilibrium constant (Keq) of the binding of each LAP to HDL. HDL distributed significantly in the adrenals (250 microliters/g), liver (80 microliters/g), and ovaries (55 microliters/g), but not in the kidneys. This suggests that the binding of HDL apoproteins to kidneys, reported by others, was due to the uptake of free apoproteins. The Keqs exhibited a log-linear relationship with respect to the acyl chain length of the LAPs. Each carbon unit added to the acyl chain decreased the free energy of This suggests that the binding of HDL apoproteins to kidneys, reported by others, was due to the uptake of free apoproteins.
Introduction
The plasma lipoproteins are water-soluble complexes that transport lipids in blood (1) (2) (3) . They have been defined according to their densities as the high density lipoproteins (HDL), low, intermediate, and very low density lipoproteins, as well as the chylomicrons. The lipoproteins are composed of a central core of neutral lipids surrounded by a monomolecular layer of polar lipids and specific apoproteins (4, 5) . Most of the polar components, including apoproteins, spontaneously exchange among lipoproteins. The mechanism oftransfer of apoproteins probably involves transport of molecular species through the aqueous phase (6) (7) (8) (9) . Consistent with this view, a pool of free apoprotein it. Therefore, the partitioning of apoproteins between lipoproteins and the aqueous phase must be considered when studying lipoprotein metabolism. This concept of partitioning has been extensively studied based on the amphipathic helical theory of lipid-binding of apoproteins proposed by Segrest et al. (12) . Hy- pothetically, when an apoprotein assumes a helical structure, the polar and the hydrophobic residues appear on opposite sides of the helix. This arrangement permits the nonpolar face of the helix to penetrate the lipid matrix and the polar face to remain in contact with the aqueous phase. This theory has now been supported by numerous reports involving natural as well as synthetic model apopeptides (13) (14) (15) (16) (17) (18) (19) (20) . These studies led to the formulation of a number of properties of native or synthetic lipid associating apoproteins, which are mainly: (a) The ability to form an amphipathic a-helix; (b) a high hydrophobicity; (c) a minimal length. Although different, these criteria are not independent; therefore, they cannot be clearly distinguished with purely peptidic molecules. To avoid this difficulty, we synthesized a family ofacylated peptides having a hydrophobic content that increases with the acyl chain length, whereas the a-helical potential and the length of the peptide remain constant. We have recently shown that these peptides bind to HDL, in vitro (21) . The dependence of this binding upon the acyl chain length of the peptide reflected a quantitative expression ofthe hydrophobic effect. We now report the in vivo binding properties and the metabolic fate of HDL containing these acylated peptides. The data have been fitted to a model that specifically includes the partitioning of these peptides between HDL and the aqueous phase.
Methods
Materials. Female Sprague-Dawley rats (180-200 g) were obtained from Texas Animal Specialties, Houston, TX. '25I-Na and '1'I-Na were purchased from Amersham Corp., Arlington Heights, IL. Fatty acid free bovine serum albumin was purchased from Sigma Chemical Co., St. Louis,MO. I-Palmitoyl-2-oleoyl-sn-glycero-3-phosphorycholine(POPC) was obtained from Avanti Polar Lipids, Inc., Birmingham, AL. Rat apo A-I as well as human apo A-I and apo A-II were purified as previously described (20) . 1 . Abbreviations used in this paper: ADV(s), apparent distribution volume(s); apo, apoprotein; BDV, bound distribution volume; BS/FS, ratio
The amino acid sequence of the acylated lipid associating peptides (LAPs) is that of the 15-amino-acid COOH-terminal fragment of the previously studied peptide LAP-20 (19) . A saturated acyl chain of various numbers of carbons (0 < n < 16) was covalently bound to the NH2-terminal serine through a peptide bond as previously described (21) .
Thus, the acylated LAPs had the structure: R.-SerSerLeuLysGluTyrTrpSerSerLeuLysGluSerPheSer. The nomenclature adopted here is of the form C,-LAP, where n is the number of carbons in the acyl chain of the LAP.
Buffers. All in vitro experiments were carried out using a buffer containing 150 mM NaCl, 0.01 M EDTA, 0.01 M sodium azide, and 10 mM Tris. HC1, pH 7.4 . The samples were injected into rats in a phosphate-buffered saline (PBS) containing 0.12 M NaCl and 0.03 M phosphate, pH 7.4.
Peptide labeling. The LAPs bearing a saturated acyl chain ofn carbons (C4-LAPs) were radioiodinated using the chloramine T method (22) . The radioiodinated peptides were separated from residual free iodine by gel filtration. Usually all radioactive preparations were used within 2 d after iodination.
Preparation ofreassembled HDL (R-HDL). POPC and apo A-I (100: 1, molar ratio) were mixed with traces of each '25l-LAP in the presence ofsodium cholate, at room temperature. The detergent was then separated from the lipid-protein complex by gel filtration on a desalting column ofBiorad P4 (Bio-Rad Laboratories, Richmond, CA) (23) . This procedure also separated the fraction of 1251-LAP that was not associated with the POPC/apo A-I complex (21) .
Serum clearance measurements. To avoid any significant formation of 125I-labeled thyroid hormones during serum decay experiments, we injected the rats intraperitoneally with I ml of potassium iodide (I mg/ ml) I d before and at the time of sample injection. Catheters were introduced into the femoral veins of rats on both sides under ether anesthesia. One catheterized vein was used for injecting the sample and the other for periodic blood sampling. Between samplings, a solution of 0.9% NaCI was infused into the catheter at a rate of I ml/h. The samples to be injected consisted of 1251-C5LAPs (5-10 X 106 cpm) either as R-HDL components or as free molecules in PBS. These two ways of preparing the samples gave indistinguishable results. The sera obtained from periodic blood sampling (100-200 ul) were counted for 125I radioactivity. The experiments were continued until the total serum radioactivity was <1% of the injected radioactivity. The serum volume was considered at 4% of body weight.
In vivo binding of 251I-LAPs to organs. Rats under ether anesthesia were injected via a femoral vein with each l2SI-LAP either as a component of R-HDL, as free molecules in PBS, or in rat serum after overnight equilibration. Injection by these three methods gave indistinguishable results and therefore all were included in subsequent calculations. The rats were exsanguinated via the abdominal aorta, 5-7 min after injection. Then, the liver, kidneys, adrenals, ovaries, spleen, abdominal muscle, heart, lungs, and stomach were immediately removed (normally within 10 min after injection). After careful cleaning, each organ was weighed and counted for 1251I radioactivity. Entire organs were counted with the exception of muscle and liver, for which only pieces were counted. In the latter case, several pieces from different parts ofthe liver were mixed before counting. The results were expressed in terms of a volume of serum having the same radioactivity; thus, the apparent distribution volumes (ADVs) had the units of,/g of organ. The nonspecific association of radioactivity with the organs, due to the presence of residual serum after removal, was estimated by measuring the organ distribution volumes of albumin (24) . This was determined after injection of 125I-albumin to specific rats or after injection of I1MI-albumin together with 125I-LAPs into the same rats. Both procedures gave equivalent results. For convenience, the organ distribution volumes of albumin will be referred to as the nonspecific distribution volumes (NSDVs).
Modeling ofLAP metabolism. The LAP ADVs were fitted to a model that has been fully developed elsewhere (25 
Results
The serum clearances of the acyl peptides were measured after a bolus intravenous injection of each 'l25-LAP. The clearance rate dramatically decreased when the acyl chain length of the LAP increased (Fig. 1 (Fig. 4) . Since the affinities of the LAPs for HDL appeared to be dependent upon their acyl chain length, we measured the in vivo binding of each 125I-LAP to organs, 10 min after injection. The results were expressed in terms of ADVs having the unit of microliters per gram of organ. We elected to measure the organassociated radioactivity after 10 min because it is a time long enough for the ADVs to reach equilibrium (24) , and sufficiently short for the radioactivity to be representative of the injected compound. Chromatography of serum on Sephadex G-25 column did not reveal the presence ofeither free radioactive iodine or I251-tyrosine. Moreover, injection of cold Nal (150 lsg/rat) with the samples did not change the ADVs in any ofthe organs tested. In the first group of experiments, the effects of peptide dose were evaluated. Since the most hydrophobic LAPs have been shown to self-associate (21), we estimated the in vitro degree of self-association of C16-LAP as a function of concentration by measuring the shift of the intrinsic fluorescence of tryptophan as previously described (21) . The shifts of X. were -1 1, -10, -7, and -1 at 100, 10, 1, and 0.1 uM, respectively. Use of lower concentrations precluded accurate fluorescence measurements.
In vivo, when only traces of '251-C16-LAP were injected into rats, the concentration of peptide in serum was too low (-2.5 nM) to permit any significant self-association. Injection of 20 or 400 independent ofthe amount ofpeptide injected and were therefore averaged for subsequent calculations. Table II shows the distribution volumes obtained with six different LAPs (Co-, C4-, C6-, C8-, C12-, and C16-LAP) and with albumin. These data were fitted to the model described in Methods.
The ADVs of the different LAPs in each organ were plotted vs. those of muscle (Fig. 6) . Muscle was chosen as a reference because it was found to be the organ presenting the least individual variability (Table II) (2), we obtained a group of six straight lines, going through the origin, whose slopes corresponded to the partition coefficients, BS/TS, of each peptide (Fig. 7) . From these, we calculated the ratio ofHDL-bound peptide to free peptide in serum, BS/FS. This ratio exhibited a loglinear relationship with respect to the acyl chain length of the LAP (Fig. 8) . The extrapolated values were used to obtain a definitive estimate of BS/TS, from which we calculated the final values of A and ADVo in each organ (equation 2). The plot of the experimental ADVs vs. BS/TS for each organ is a straight line whose slope is -A and the y intercept is ADVo (Fig. 9 ).
From these estimates we used equation 2 to obtain the "calculated values" of ADVj and we plotted them vs. the experimental ADVij (Fig. 10) . The high correlation obtained (r = 0.984) clearly showed the overall validity of the model. Finally, we calculated FDVi and BDV, and verified the accuracy ofthe model for each individual organ as follows: we observed (Fig. 8) (Fig.   1 1) . This validated the estimates of BDVi, FDVi, and BSj/FSj, which could be considered as being of physiological relevance.
The analysis of BDVi and FDVi confirmed the results suggested by the l-d experiments mentioned above (Fig. 12) . The free peptide was nearly homogeneously distributed into all organs with the exception of kidneys, where FDV was clearly higher. In contrast, significant quantities of the HDL-bound peptide were associated with only three organs: adrenals, liver, and ovaries. Although adrenals contained more HDL-bound peptide per gram of tissue, the liver had the largest HDL distribution 382±38  447±32  375±8  142±2  314±16  444±24  379±8  9  415±28  1,027±27  368±30  421±16  378±38  151±15  296±19  421±28  344±37  90  446±10  928±31  421±29  484±21  363±17  162±3  344±18  473±23  385±27   C16-LAP   Traces  139±23  106±23  319±30  125±2  75±7  19±3  52±9  70±9  16±3  20 145±5
Traces of '25I-LAPs were injected with increasing amounts of the same nonradioactive LAPs. The distribution volumes per gram of organs were determined 10 min after injection. Values are given as the mean±SEM of four rats.
volume per total organ (600 yl). The estimates of BDV1 were very close to the organ distribution volumes observed after injection of rat 125I-apo A-I-labeled HDL, with the exception of kidneys. The kidney BDVi was close to nil, whereas this organ exhibited extensive labeling after injection of rat '25I-apo A-Ilabeled HDL (Fig. 12) . (21) . The two groups of Kqs were strictly correlated (r = 0.985; Fig. 13 ). For each LAP, the in vivo and in vitro K.,s were of the same order of magnitude, although the former were approximately three times higher than the latter.
Discussion
There is a growing body of evidence indicating that apoproteins undergo a partitioning between lipoproteins and the aqueous phase of serum (6-1 1 Figure 6 . First estimates of the model parameters. The apparent distribution volumes in organs of the C.-LAPs (ADVs) were plotted vs.
those obtained in muscle, according to the model described under
Methods (equation 3)
. From the slopes and the yintercepts of these straight lines, we calculated, respectively, A and ADVO in each organ.
A is the difference between the distribution volumes of the free and HDL bound LAP. ADVO is the apparent distribution volume of a theoretical LAP whose affinity for HDL is nil.
LAPs whose acyl chain length varied from 0 to 16 Other parameters are defined in Fig. 5 (28) . BS/FS was calculated as described in the legend to Fig. 7 . In vitro KYqs were those calculated in a previous work (21) .
LAP between HDL and the aqueous phase of serum. From these partition coefficients, we calculated the corresponding equilibrium constants (K4nqs). These were strictly correlated with the corresponding values previously obtained in vitro (21 there is a log-linear relationship between Kqs and the number of carbon units of the LAP acyl chain, and (c) in both cases, the contribution of each carbon unit to AGa is identical. These notable similarities clearly show that the hydrophobic properties of the LAPs are fully expressed in vivo. This illustrates the large effect of hydrophobicity on the binding of the LAPs to HDL, which went from virtually 0 with Co-LAP to 100% with C16-LAP. Finally, our work shows that a rule that we previously established in vitro applies in vivo: for a given family of apolipopeptides having a constant putative a-helicity and a constant amphipathic length, the binding to lipid surfaces is governed by their hydrophobicity. Therefore, an important factor that regulates the partitioning and catabolism of a given apoprotein is its relative solubility in the aqueous phase of serum and in the lipid surface of its specific lipoprotein carrier. The question as to whether this rule applies in other species including humans has not been directly answered in this work. However, it should be pointed out that the hydrophobic interaction results from intrinsic physico-chemical properties of the lipoprotein-apoprotein complex. Therefore, its generalization seems reasonable, although this does not exclude the possibility of additional less conventional mechanisms of lipoprotein-apoprotein interaction resulting from a specific biological process which might occur in a given species.
Biological implications ofthe hydrophobic effect. Our demonstration of the role of hydrophobicity on the lipoproteinapoprotein interactions might be generalized to other systems. Indeed, several naturally occurring substances including some hormones, vitamins, or carcinogens are relatively hydrophobic. Thus, their lipid solubility might affect their metabolic fate. On the other hand, our study emphasizes the possibility of varying the hydrophobicity ofcertain drugs as a way ofimproving control of their metabolism and/or pharmacological effects. From this viewpoint our study of acylated LAPs shows that the alteration of the hydrophobic properties of a compound may have highly predictable metabolic consequences.
